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Conclusion: The new treatment regimens showed excellent
outcome and safety proﬁle to be used within the programme set-
tings. On the basis of these results, Indian national program have
revised the treatment policy in Sep 2014 where SDA has been rec-
ommended as the 1st option and M+P as the 2nd option. Extension
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Background: Post-kala-azar dermal leishmaniasis (PKDL), a
cutaneous sequela of visceral leishmaniasis (VL), develops in
approximately 10% of treated VL patients in the Indian subconti-
nent and may act as a reservoir of disease. Current evidence for
treatment is limited; only long and toxic treatments currently exist
for a condition that is more a public health rather than an individ-
ual health problem. We describe the characteristics and outcome
of PKDL treated with liposomal amphotericin B (AmBisome®) in
MSF-supported facilities in India and Bangladesh.
Methods & Materials: We administered intravenous liposomal
amphotericin B 30 mg/kg body weight in 6 divided doses over 3
weeks on an ambulatory basis to patients with PKDL. To assess the
treatment response, trained physicians regularly scored the sever-
ity of lesions and took medical photographs at baseline and during
follow-up visits. The main end-points were safety of treatment,
with an emphasis on development of hypokalaemia, and efﬁcacy
at 12 months’ follow-up. Following safety concerns in Bangladesh,
we introduced a lower dose of 15mg/kg, given in 5 doses of 3mg/kg
over 3 weeks.
Results: 223 patients initiated treatmentwith the 30mg/kg reg-
imen, 110 in Bangladesh and 113 in India. In India, of 72 patients
who completed 12 months’ follow-up, 59 (82.2%) cases showed
substantial or compete cure, with excellent tolerance and safety.
In Bangladesh, of 88 patients who completed 12 months’ follow-
up, 70 (79.5%) showed substantial or complete cure; however,
6.5% developed severe hypokalaemia. No patients in either group
developed rhabdomyolysis or further sequelae. In Bangladesh, 278
patients were subsequently treated with the 15mg/kg regimen;
12-month follow-up results are available for 167. Of these, 147
(83%) showed substantial or complete cure. The safety proﬁle was
excellent with no severe hypokalaemia. We expect all results to be
available by March.
Conclusion: Short-course liposomal amphotericin B treatment
regimens for PKDL appeared to be effective and may be considered
as an option for the treatment of PKDL patients in India when bio-
chemical monitoring is available. However, levels of hypokalaemia
seen in Bangladeshi patients meant that a lower dosage regimen is
necessary, which appears to be safe and effective.
http://dx.doi.org/10.1016/j.ijid.2016.02.178
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Background: Leishmania (L.) donovani, a species of the L. dono-
vani complex, causes fatal visceral leishmaniasis (VL) disease in the
Indian Subcontinent, parts of Asia and a large part of Africa. Genetic
variations in Leishmania cause heterogeneity, spread of virulent
strains, resistance to chemotherapeutics and exploitation of differ-
ent hosts and vectors. Previously, L. donovani strains in the Indian
subcontinent were detected genetically homogeneous by MLMT.
Later study using genome-wide single nucleotide polymorphism
(SNP) markers showed that genetic variation existed in L. donovani
strains isolated from Nepal and India. We aimed to reveal intra-
species genetic variation between strains of L. donovani derived
from Bangladesh.
Methods & Materials: Twenty two newly isolated L. dono-
vani strains from VL cases were investigated in a cross sectional
study by MLST of seven functionally independent housekeeping
genes located in different chromosomes. Target loci were rhom-
boid like serine protease, fatty acid/sphingolipid -4 desaturase,
serine/threonine-protein kinase, 5’ A2rel-related gene, ubiquitin-
activating enzyme e1, mannosyltransferase and splicing factor
3B subunit1 gene. Sequences of respective genes of L. donovani
retrieved from GenBank and that obtained after sequencing of
reference strains of L. donovani and L. infantum were used for com-
parison.
Results: Unambiguous sites of SNPs were detected in analysed
sequences across all loci. The 5’ a2rel-related locus was the most
diverge region with 26 SNPs, followed by mannosyltransferase
with 10, splicing factor 3B subunit1 with 6, ubiquitin-activating
enzyme e1 with 5, rhomboid like serine protease with 4; fatty
acid/sphingolipid -4 desaturase and serine/threonine-protein
kinase possessed 1 SNPeach. Two large closely related clusters (one
contained 10 and the other 7 isolates) and ﬁve separate individual
groups among 22 Bangladeshi isolates were revealed by phylo-
genetic analysis showing the presence of 7 genotypes among L.
donovani strains in the country.
Conclusion: The study illustrates that intra-species genetic
diversity between strains of L. donovani does exist in Bangladesh.
A combination of sequencing of 5’ a2rel-related gene and manno-
syltransferase gene are sufﬁcient to differentiate strains of the L.
donovani. The MLST can be a future tool to determine intra- and
inter-species genetic variation of Leishmania.
http://dx.doi.org/10.1016/j.ijid.2016.02.179
